The aim of this study was to assess the serum TK1 and FORα expression in prostate cancer patients by ELISA and to correlate their levels with the severity of the disease, as well as studying their correlation with another well-documented prostate cancer marker (PSA) for a possible higher diagnostic accuracy through improved sensitivity and/ or specificity. The gene discussed is KLK3; the disease is prostate carcinoma.